(NASDAQ: IDXX) Idexx Laboratories's forecast annual revenue growth rate of 7.13% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Idexx Laboratories's revenue in 2025 is $3,931,836,000.On average, 7 Wall Street analysts forecast IDXX's revenue for 2025 to be $332,279,154,047, with the lowest IDXX revenue forecast at $330,509,952,295, and the highest IDXX revenue forecast at $337,257,351,131. On average, 7 Wall Street analysts forecast IDXX's revenue for 2026 to be $358,219,404,219, with the lowest IDXX revenue forecast at $354,338,966,302, and the highest IDXX revenue forecast at $365,067,250,030.
In 2027, IDXX is forecast to generate $389,790,877,442 in revenue, with the lowest revenue forecast at $386,025,201,600 and the highest revenue forecast at $395,008,329,729.